PsiQuantum and AMD Expand Partnership on Quantum Computing Infrastructure
AI-summarised brief · reviewed before publication
PsiQuantum and AMD have broadened their partnership to co‑design the classical and quantum infrastructure needed for large‑scale, fault‑tolerant quantum systems and hybrid applications. The collaboration now includes AMD Instinct GPUs, EPYC CPUs, and the ROCm software stack alongside PsiQuantum’s silicon photonics platform, with AMD planning an equity stake in PsiQuantum. Initial efforts target pharmaceutical research, building on GPU‑based simulations of covalent inhibitors and a machine‑learning decoder for real‑time error correction. The alliance aligns with U.S. Department of Energy priorities for quantum‑enabled drug discovery.
💡 Why It Matters
- · By merging AMD’s high‑performance compute assets with PsiQuantum’s photonic quantum platform, the partnership accelerates the development of practical, utility‑scale quantum machines that can tackle complex drug‑discovery challenges, a critical step toward realizing quantum advantage in life sciences.